GeoWealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
GeoWealth Management's BMY Position: Q2 2026 in Review
GeoWealth Management reduced its Bristol-Myers Squibb (BMY) stake by 43% in Q2 2026, selling an estimated $444K and leaving 10,113 shares worth $583K. The position accounts for 0.02% of the portfolio, ranked #467.
GeoWealth Management first reported a position in BMY in Q3 2019 and has held it in 18 quarters since. The position peaked at $1.08M in Q1 2026. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- GeoWealth Management held 10,113 shares of Bristol-Myers Squibb worth $583K as of Q2 2026.
- GeoWealth Management sold 7,737 Bristol-Myers Squibb shares in Q2 2026, an estimated $444K.
- Bristol-Myers Squibb made up 0.02% of GeoWealth Management's portfolio in Q2 2026, its #467 holding.
- GeoWealth Management first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 18 quarters since.
- GeoWealth Management's Bristol-Myers Squibb position peaked at $1.08M in Q1 2026.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on GeoWealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.